176 related articles for article (PubMed ID: 16012995)
21. Emergence of adenomatous aberrant crypt foci (ACF) from hyperplastic ACF with concomitant increase in cell proliferation.
Otori K; Sugiyama K; Hasebe T; Fukushima S; Esumi H
Cancer Res; 1995 Nov; 55(21):4743-6. PubMed ID: 7585496
[TBL] [Abstract][Full Text] [Related]
22. APC and K-ras gene mutation in aberrant crypt foci of human colon.
Yuan P; Sun MH; Zhang JS; Zhu XZ; Shi DR
World J Gastroenterol; 2001 Jun; 7(3):352-6. PubMed ID: 11819789
[TBL] [Abstract][Full Text] [Related]
23. Mutations in BRAF and KRAS differentially distinguish serrated versus non-serrated hyperplastic aberrant crypt foci in humans.
Rosenberg DW; Yang S; Pleau DC; Greenspan EJ; Stevens RG; Rajan TV; Heinen CD; Levine J; Zhou Y; O'Brien MJ
Cancer Res; 2007 Apr; 67(8):3551-4. PubMed ID: 17440063
[TBL] [Abstract][Full Text] [Related]
24. Identification and quantification of aberrant crypt foci and microadenomas in the human colon.
Roncucci L; Stamp D; Medline A; Cullen JB; Bruce WR
Hum Pathol; 1991 Mar; 22(3):287-94. PubMed ID: 1706308
[TBL] [Abstract][Full Text] [Related]
25. Aberrant crypt foci in colorectal carcinogenesis. Cell and crypt dynamics.
Roncucci L; Pedroni M; Vaccina F; Benatti P; Marzona L; De Pol A
Cell Prolif; 2000 Feb; 33(1):1-18. PubMed ID: 10741640
[TBL] [Abstract][Full Text] [Related]
26. Oncogenic K-ras promotes early carcinogenesis in the mouse proximal colon.
Calcagno SR; Li S; Colon M; Kreinest PA; Thompson EA; Fields AP; Murray NR
Int J Cancer; 2008 Jun; 122(11):2462-70. PubMed ID: 18271008
[TBL] [Abstract][Full Text] [Related]
27. Identification and quantification of aberrant crypt foci in the colon of Min mice--a murine model of familial adenomatous polyposis.
Paulsen JE; Namork E; Steffensen IL; Eide TJ; Alexander J
Scand J Gastroenterol; 2000 May; 35(5):534-9. PubMed ID: 10868458
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of aberrant crypt foci by chemopreventive agents.
Olivo S; Wargovich MJ
In Vivo; 1998; 12(2):159-66. PubMed ID: 9627797
[TBL] [Abstract][Full Text] [Related]
29. Epidermal growth factor receptor signaling is up-regulated in human colonic aberrant crypt foci.
Cohen G; Mustafi R; Chumsangsri A; Little N; Nathanson J; Cerda S; Jagadeeswaran S; Dougherty U; Joseph L; Hart J; Yerian L; Tretiakova M; Yuan W; Obara P; Khare S; Sinicrope FA; Fichera A; Boss GR; Carroll R; Bissonnette M
Cancer Res; 2006 Jun; 66(11):5656-64. PubMed ID: 16740703
[TBL] [Abstract][Full Text] [Related]
30. Mutations of the Apc gene in experimental colorectal carcinogenesis induced by azoxymethane in F344 rats.
De Filippo C; Caderni G; Bazzicalupo M; Briani C; Giannini A; Fazi M; Dolara P
Br J Cancer; 1998 Jun; 77(12):2148-51. PubMed ID: 9649126
[TBL] [Abstract][Full Text] [Related]
31. Phenotypic and genotypic characteristics of aberrant crypt foci in human colorectal mucosa.
Nucci MR; Robinson CR; Longo P; Campbell P; Hamilton SR
Hum Pathol; 1997 Dec; 28(12):1396-407. PubMed ID: 9416697
[TBL] [Abstract][Full Text] [Related]
32. Glutathione S-transferase-pi overexpression is closely associated with K-ras mutation during human colon carcinogenesis.
Miyanishi K; Takayama T; Ohi M; Hayashi T; Nobuoka A; Nakajima T; Takimoto R; Kogawa K; Kato J; Sakamaki S; Niitsu Y
Gastroenterology; 2001 Oct; 121(4):865-74. PubMed ID: 11606500
[TBL] [Abstract][Full Text] [Related]
33. Frequent beta-catenin gene mutations and accumulations of the protein in the putative preneoplastic lesions lacking macroscopic aberrant crypt foci appearance, in rat colon carcinogenesis.
Yamada Y; Yoshimi N; Hirose Y; Kawabata K; Matsunaga K; Shimizu M; Hara A; Mori H
Cancer Res; 2000 Jul; 60(13):3323-7. PubMed ID: 10910031
[TBL] [Abstract][Full Text] [Related]
34. Gene expression patterns distinguish colonoscopically isolated human aberrant crypt foci from normal colonic mucosa.
Glebov OK; Rodriguez LM; Soballe P; DeNobile J; Cliatt J; Nakahara K; Kirsch IR
Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2253-62. PubMed ID: 17119054
[TBL] [Abstract][Full Text] [Related]
35. Natural history of aberrant crypt foci. A surgical approach.
Shpitz B; Hay K; Medline A; Bruce WR; Bull SB; Gallinger S; Stern H
Dis Colon Rectum; 1996 Jul; 39(7):763-7. PubMed ID: 8674368
[TBL] [Abstract][Full Text] [Related]
36. Increased levels of PPARbeta/delta and cyclin D1 in flat dysplastic ACF and adenomas in Apc(Min/+) mice.
Knutsen HK; Olstørn HB; Paulsen JE; Husøy T; Goverud IL; Løberg EM; Kristiansen K; Alexander J
Anticancer Res; 2005; 25(6B):3781-9. PubMed ID: 16309164
[TBL] [Abstract][Full Text] [Related]
37. K-ras mutations and mucin profile in preneoplastic lesions and colon tumors induced in rats by 1,2-dimethylhydrazine.
Femia AP; Tarquini E; Salvadori M; Ferri S; Giannini A; Dolara P; Caderni G
Int J Cancer; 2008 Jan; 122(1):117-23. PubMed ID: 17847023
[TBL] [Abstract][Full Text] [Related]
38. Aberrant crypt foci in patients with neoplastic and nonneoplastic colonic disease.
Bouzourene H; Chaubert P; Seelentag W; Bosman FT; Saraga E
Hum Pathol; 1999 Jan; 30(1):66-71. PubMed ID: 9923929
[TBL] [Abstract][Full Text] [Related]
39. Altered expression of beta-catenin, inducible nitric oxide synthase and cyclooxygenase-2 in azoxymethane-induced rat colon carcinogenesis.
Takahashi M; Mutoh M; Kawamori T; Sugimura T; Wakabayashi K
Carcinogenesis; 2000 Jul; 21(7):1319-27. PubMed ID: 10874009
[TBL] [Abstract][Full Text] [Related]
40. [Aberrant crypt foci as biomarkers in chemoprevention for colorectal cancer].
Katsuki S; Oui M; Takayama T; Takahashi Y; Shuichi N; Niitsu Y
Nihon Geka Gakkai Zasshi; 1998 Jun; 99(6):379-84. PubMed ID: 9695076
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
